Skip to main content
City of South San Francisco header
File #: 25-401    Name:
Type: Resolution Status: Passed
File created: 4/14/2025 In control: City Council
On agenda: 6/25/2025 Final action: 6/25/2025
Title: Resolution making findings and approving amendments to the Genentech 2020 Master Plan and associated General Plan Amendments.
Attachments: 1. Exhibit A - Genentech Master Plan Amendments, 2. Exhibit B - General Plan Amendments
Related files: 25-398, 25-399, 25-400, 25-644, 25-397
Title
Resolution making findings and approving amendments to the Genentech 2020 Master Plan and associated General Plan Amendments.

body
WHEREAS, in 2020 the City of South San Francisco ("City") adopted (1) Resolution No. 169-2020 certifying the Environmental Impact Report, including adoption of the Statement of Overriding Considerations and the Mitigation Monitoring and Reporting Program, for the Genentech 2020 Master Plan Update (State Clearinghouse No. 2017052064, (2) Resolution No. 170-2020 adopting the Genentech 2020 Master Plan Update, and (3) Ordinance No. 1614-2020 amending Chapter 20.260 of the South San Francisco Municipal Code related to the Genentech Master Plan Zoning District; and

WHEREAS, the Genentech 2020 Master Plan guides the development of the Genentech campus over a period of fifteen (15) years to create a vibrant, transit supported, state of the art research, office, and manufacturing campus for the life sciences; and

WHEREAS, Genentech, Inc. ("Owner" or "Applicant") has submitted an application requesting acquisition of certain public rights-of-way (DNA Way, Point San Bruno Boulevard, and Cabot Road) within the Genentech Campus Master Plan boundaries, and to add the vacated streets and private properties at 333 Point San Bruno Boulevard (APNs 015-250-410 and 015-250-140), 525 DNA Way (APN 015-250-210), and 383-393 East Grand Avenue (APN 015-250-390) to the Genentech Campus Master Plan ("Project"); and

WHEREAS, the Applicant has proposed amendments to the Genentech 2020 Master Plan to incorporate the new private parcels and to reflect the ability to close certain portion of the roadways to public traffic if the terms and conditions of the purchase and sale agreement and maintenance and license agreement are met; and

WHEREAS, the Applicant has proposed amendments to the General Plan to ensure internal consistency between the Genentech 2020 Master Plan and the General Plan, which include changes to the designation of DNA Way; and

WHERE...

Click here for full text